Compounded Tirzepatide Vials Recalled Over Sterility Concerns, Not Lilly's Mounjaro or Zepbound
Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources
Brief
North Carolina compounder Apothecary Pharma is pulling 22 vials of its tirzepatide…
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.
3 sources behind this story.